CYP2C9
MOLECULAR TARGETcytochrome P450 family 2 subfamily C member 9
CYP2C9 (cytochrome P450 family 2 subfamily C member 9) is targeted by 295 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting CYP2C9
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
Showing top 50 of 295 compounds. Use the BiohacksAI search to explore all CYP2C9 modulators.
About CYP2C9 as a Drug Target
CYP2C9 (cytochrome P450 family 2 subfamily C member 9) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 295 compounds with documented CYP2C9 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
CYP2C9 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.